“First-hand insights from each step of the journey as a biotech entrepreneur”
On March 3, we are pleased to welcome Mai-Britt Zocca to BioInnovation Institute as she will host a ‘Talk at the Square.’ Based on her vast experience in founding and heading several biotech companies, she will share her learnings on bringing academic discoveries to the market to benefit patients who lack treatment options.
Mai-Britt will use her current position as CEO of Nasdaq-listed IO Biotech and her background in operating in early-stage start-ups to provide unique insights to the audience about the different challenges you are coping with in each step of the journey of bringing a drug onto the market.
Program of the day:
15.30 Doors open
16.00 Introduction to BII and the subject of the day: Jens Nielsen, CEO at BII
16.10 Keynote speaker: Mai-Britt Zocca “First-hand insights from each step of the journey as a biotech entrepreneur”
16.40 Fireside chat with Jens Nielsen and questions
17.00 Informal networking and closing reception
Please note that the event has free admittance with 60 tickets available. Please sign up quickly to secure your seat.
If you have registered for the event but cannot attend, please email email@example.com.
About Mai-Britt Zocca:
Dr. Zocca has served as Founder and Chief Executive Officer of IO Biotech since January 2015. Dr. Zocca was also the founder and Chief Executive Officer of OncoNOx ApS, a pharmaceutical company, from July 2011 until May 2019. Prior to founding the Company, she was the Chief Executive Officer at LevOss ApS, a biotechnology company, from January 2012 until January 2017. Dr. Zocca also led DanDrit Biotech A/S, a biotechnology company, as its Chief Executive Officer from July 2007 until December 2010. Dr. Zocca currently serves on the board of directors for Dansk Biotek, a Danish biotechnology trade organization, and Valo Therapeutics Ltd., a biotechnology company. Dr. Zocca received her M.Sc in Biochemistry as well as Ph.D. in Medicine from the University of Copenhagen and NIH, NCI, MD, US.